StimCardio Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$30M
- Investors
-
12
StimCardio General Information
Description
Developer of a wearable device designed for non-invasive treatment and monitoring of atrial fibrillation at home. The company's device is based on a closed-loop approach and machine learning algorithms that utilize non-invasive, personalized peripheral neuromodulation to mediate a cardiovascular antiarrhythmic response, enabling patients to reduce the burden of atrial fibrillation and its precursors, resulting in rapid clinical and symptomatic relief.
Contact Information
Website
www.stimcardio.comCorporate Office
- 1925 Century Park East
- Suite 1700
- Los Angeles, CA 90067
- United States
Corporate Office
- 1925 Century Park East
- Suite 1700
- Los Angeles, CA 90067
- United States
StimCardio Timeline
StimCardio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 29-Oct-2026 | $30M | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 07-Oct-2025 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Aug-2023 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jun-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Aug-2018 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
StimCardio Patents
StimCardio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026229977-A1 | Methods and systems for managing stress such as in anxiety | Pending | 29-Apr-2025 | ||
| WO-2025243290-A1 | Post ablation autonomic nervous system neuromodulation treatment | Pending | 20-May-2024 | ||
| EP-4277699-A1 | Monitoring and treating atrial fibrillation, arrythmia, and additional conditions | Pending | 18-Jan-2021 | ||
| EP-4277699-A4 | Monitoring and treating atrial fibrillation, arrythmia, and additional conditions | Pending | 18-Jan-2021 | ||
| US-20240091533-A1 | Monitoring and treating atrial fibrillation, arrythmia, and additional conditions | Pending | 18-Jan-2021 | A61N1/36031 |
StimCardio Signals
StimCardio Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Catalyst Health Ventures | Venture Capital | Minority | ||
| MedTech Angels | Angel Group | Minority | ||
| Metis Medtech | Venture Capital | Minority | ||
| New Mexico Angels | Angel Group | Minority | ||
| New York Angels | Angel Group | Minority |
StimCardio FAQs
-
When was StimCardio founded?
StimCardio was founded in 2018.
-
Where is StimCardio headquartered?
StimCardio is headquartered in Los Angeles, CA.
-
What is the size of StimCardio?
StimCardio has 6 total employees.
-
What industry is StimCardio in?
StimCardio’s primary industry is Therapeutic Devices.
-
Is StimCardio a private or public company?
StimCardio is a Private company.
-
What is StimCardio’s current revenue?
The current revenue for StimCardio is .
-
How much funding has StimCardio raised over time?
StimCardio has raised $30M.
-
Who are StimCardio’s investors?
Catalyst Health Ventures, MedTech Angels, Metis Medtech, New Mexico Angels, and New York Angels are 5 of 12 investors who have invested in StimCardio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process